Key statistics
As of last trade Hansa Biopharma AB (24H:DUS) traded at 3.45, -9.44% below its 52-week high of 3.81, set on Oct 01, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.46 |
|---|---|
| High | 3.47 |
| Low | 3.40 |
| Bid | 3.46 |
| Offer | 3.54 |
| Previous close | 3.45 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 101.76m |
| Free float | 65.58m |
| P/E (TTM) | -- |
| Market cap | 3.76bn SEK |
| EPS (TTM) | -8.90 SEK |
Data delayed at least 15 minutes, as of Feb 10 2026 18:31 GMT.
More ▼
Press releases
- Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hansa Biopharma has won the 2025 SwedenBIO Award
- Hansa Biopharma has won the 2025 SwedenBIO Award
- Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
- Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
More ▼
